William Alan Haseltine
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
William Alan Haseltine has a total of 12 co-authors. Here are the top co-authors by number of shared publications:
- Roberto Patarca
ACCESS Health International
29 shared publications Chang Liu
ACCESS Health International
2 shared publications- Kim Hazel
ACCESS Health International, 384 West Lane, Ridgefield, CT 06877, USA
2 shared publications Andrew Dayton
Dana-Farber Cancer Institute, Department of Pathology, Harvard Medical School, Massachusetts, USA
1 shared publicationCraig Rosen
Dana-Farber Cancer Institute, Department of Pathology, Harvard Medical School, Massachusetts, USA
1 shared publicationErnest Terwilliger
Dana-Farber Cancer Institute, Department of Pathology, Harvard Medical School, Massachusetts, USA
1 shared publication
Latest Publications
- Open Access
- 13 November 2026
- Published by MDPI AG in International Journal of Molecular Sciences
- Vol. 27 (22) , 10192
Form and Function in Flux: Molecular Ensembles from Structure to Therapy
Molecular structure, revealed by crystallography, cryo-electron microscopy, imaging, and prediction, remains foundational to biology and drug design, yet function also depends on how structures flex, adapt, and interact. Proteins and RNA populate alternative conformations and binding states, while chromatin, membranes, glycans, metabolites, water, ions, and biominerals vary in composition and organization. This narrative review treats form and function as interdependent properties of molecular ensembles: structure constrains which states are accessible, whereas regulatory inputs, partners, and cellular environments determine which states are occupied, exchanged, and used. Without assuming a shared physical mechanism, we compare these systems and propose a cross-class evidence map that links each claimed state variable to its regulatory input, matched measurement, causal test, and organismal or clinical outcome. Examples from cancer, neurodegeneration, infection, and metabolic disease show how specific states become dysregulated, and why restored binding, assembly, or imaging readouts need not indicate functional recovery. Therapies are compared by primary mode of action—direct state modulation, target-abundance reduction, or genetic and RNA-level correction—with clinical successes, failures, and safety limits reported separately. The synthesis identifies where measurement methods must advance to resolve interrelated ensembles in native contexts and to determine when targeting them yields meaningful patient benefit.
- 13 November 2026
- Published by MDPI AG in International Journal of Molecular Sciences
- Vol. 27 (22) , 10192
Open AccessForm and Function in Flux: Molecular Ensembles from Structure to Therapy
Molecular structure, revealed by crystallography, cryo-electron microscopy, imaging, and prediction, remains foundational to biology and drug design, yet function also depends on how structures flex, adapt, and interact. Proteins and RNA populate alternative conformations and binding states, while chromatin, membranes, glycans, metabolites, water, ions, and biominerals vary in composition and organization. This narrative review treats form and function as interdependent properties of molecular ensembles: structure constrains which states are accessible, whereas regulatory inputs, partners, and cellular environments determine which states are occupied, exchanged, and used. Without assuming a shared physical mechanism, we compare these systems and propose a cross-class evidence map that links each claimed state variable to its regulatory input, matched measurement, causal test, and organismal or clinical outcome. Examples from cancer, neurodegeneration, infection, and metabolic disease show how specific states become dysregulated, and why restored binding, assembly, or imaging readouts need not indicate functional recovery. Therapies are compared by primary mode of action—direct state modulation, target-abundance reduction, or genetic and RNA-level correction—with clinical successes, failures, and safety limits reported separately. The synthesis identifies where measurement methods must advance to resolve interrelated ensembles in native contexts and to determine when targeting them yields meaningful patient benefit.
- Open Access
- 28 October 2026
- Published by MDPI AG in Preprints.org
Form and Function in Flux: Molecular Ensembles from Structure to Therapy
Molecular structure, revealed by crystallography, cryo-electron microscopy, imaging, and prediction, remains foundational to biology and drug design, yet function also depends on how structures flex, adapt, and interact. Proteins and RNA populate alternative conformations and binding states, while chromatin, membranes, glycans, metabolites, water, ions, and biominerals vary in composition and organization. This narrative review treats form and function as interdependent properties of molecular ensembles: structure constrains which states are accessible, whereas regulatory inputs, partners, and cellular environments determine which states are occupied, exchanged, and used. Without assuming a shared physical mechanism, we compare these systems and propose a cross-class evidence map that links each claimed state variable to its regulatory input, matched measurement, causal test, and organismal or clinical outcome. Examples from cancer, neurodegeneration, infection, and metabolic disease show how specific states become dysregulated, and why restored binding, assembly, or imaging readouts need not indicate functional recovery. Therapies are compared by primary mode of action—direct state modulation, target-abundance reduction, or genetic and RNA-level correction—with clinical successes, failures, and safety limits reported separately. The synthesis identifies where measurement methods must advance to resolve interrelated ensembles in native contexts and to determine when targeting them yields meaningful patient benefit.
- 28 October 2026
- Published by MDPI AG in Preprints.org
Open AccessForm and Function in Flux: Molecular Ensembles from Structure to Therapy
Molecular structure, revealed by crystallography, cryo-electron microscopy, imaging, and prediction, remains foundational to biology and drug design, yet function also depends on how structures flex, adapt, and interact. Proteins and RNA populate alternative conformations and binding states, while chromatin, membranes, glycans, metabolites, water, ions, and biominerals vary in composition and organization. This narrative review treats form and function as interdependent properties of molecular ensembles: structure constrains which states are accessible, whereas regulatory inputs, partners, and cellular environments determine which states are occupied, exchanged, and used. Without assuming a shared physical mechanism, we compare these systems and propose a cross-class evidence map that links each claimed state variable to its regulatory input, matched measurement, causal test, and organismal or clinical outcome. Examples from cancer, neurodegeneration, infection, and metabolic disease show how specific states become dysregulated, and why restored binding, assembly, or imaging readouts need not indicate functional recovery. Therapies are compared by primary mode of action—direct state modulation, target-abundance reduction, or genetic and RNA-level correction—with clinical successes, failures, and safety limits reported separately. The synthesis identifies where measurement methods must advance to resolve interrelated ensembles in native contexts and to determine when targeting them yields meaningful patient benefit.
- 22 August 2026
- Published by Springer Nature
- p. 245-294
Small Noncoding RNAs: Small Interfering RNAs and Piwi-interacting RNAs
- 22 August 2026
- Published by Springer Nature
- p. 245-294
Small Noncoding RNAs: Small Interfering RNAs and Piwi-interacting RNAs
- 22 August 2026
- Published by Springer Nature
- p. 219-243
Small Noncoding RNAs: Vault RNAs and Agotrons
- 22 August 2026
- Published by Springer Nature
- p. 39-75
Long Noncoding RNAs: Localization, Structure, and Interactions with Other Molecules
- 22 August 2026
- Published by Springer Nature
- p. 39-75
Long Noncoding RNAs: Localization, Structure, and Interactions with Other Molecules
- 22 August 2026
- Published by Springer Nature
- p. 1-37
Long Noncoding RNAs: Characteristics, Microprotein Production, and Genomic Origins
- 22 August 2026
- Published by Springer Nature
- p. 1-37
Long Noncoding RNAs: Characteristics, Microprotein Production, and Genomic Origins
- 2 August 2026
- Published by Springer Nature
- p. 269-298
Ribosomal RNAs and Derived Fragments
- 2 August 2026
- Published by Springer Nature
- p. 37-81
RNA Types
- 2 August 2026
- Published by Springer Nature
- p. 1-36
Foundations of DNA and RNA Biology